Cara Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CARA and buy or sell other stocks, ETFs, and their options commission-free!About CARA
Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
CEOImran Alibhai, PhD
CEOImran Alibhai, PhD
Employees10
Employees10
HeadquartersSugar Land, Texas
HeadquartersSugar Land, Texas
Founded
Founded
Employees10
Employees10
CARA Key Statistics
Market cap24.33M
Market cap24.33M
Price-Earnings ratio-0.83
Price-Earnings ratio-0.83
Dividend yield—
Dividend yield—
Average volume159.97K
Average volume159.97K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$34.31
52 Week high$34.31
52 Week low$8.13
52 Week low$8.13
People also own
Based on the portfolios of people who own CARA. This list is generated using Robinhood data, and it’s not a recommendation.